48,830
edits
m (note about MALT lymphoma) |
(→Table of B-cell lymphoma: more info in table) |
||
Line 25: | Line 25: | ||
| CD10+, BCL6+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | | CD10+, BCL6+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | ||
| t(14,18) | | t(14,18) | ||
| | | may transform into DLBCL | ||
| | | cery common | ||
|- | |- | ||
| Mantle cell lymphoma | | Mantle cell lymphoma | ||
Line 34: | Line 34: | ||
| t(11;14)(q13;q32)<ref>URL: [http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html]. Accessed on: 10 August 2010.</ref> | | t(11;14)(q13;q32)<ref>URL: [http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html]. Accessed on: 10 August 2010.</ref> | ||
| Clinical ? | | Clinical ? | ||
| | | DDx: [[Castleman disease]] | ||
|- | |- | ||
| Marginal zone lymphoma (MALT) | | Marginal zone lymphoma (includes MALT) | ||
| Marginal zone | | Marginal zone | ||
| Small | | Small | ||
| CD21+, CD11c+, CD5-, CD23-<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | | CD21+, CD11c+, CD5-, CD23-<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | ||
| Translocations | | Translocations | ||
| | | classical GI lymphomas | ||
| Other | | Other | ||
|- | |- | ||
Line 49: | Line 49: | ||
| CD10+, CD5-, TdT+, CD99+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | | CD10+, CD5-, TdT+, CD99+<ref name=Ref_Lester95>{{Ref Lester|95}}</ref> | ||
| Translocations ? | | Translocations ? | ||
| | | aggressive (?) | ||
| Other ? | | Other ? | ||
|- | |- | ||
Line 57: | Line 57: | ||
| CD5+, CD23+, CD43+, cyclin D1- | | CD5+, CD23+, CD43+, cyclin D1- | ||
| Translocations ? | | Translocations ? | ||
| | | good prognosis / indolent course | ||
| Other ? | | Other ? | ||
|- <!-- | |- <!-- |
edits